Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 7, 1996, Pages 667-671

  Yurdaydin, Cihan ^a,c,d   Herneth, Andreas M ^a   Püspök, Andreas ^a   Steindl, Petra ^a   Singer, Ernst ^b   Ferenci, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c ANKARA UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Hepatic encephalopathy; Methysergide; Seganserin; Thioacetamide

Indexed keywords

METHYSERGIDE; SEGANSERIN; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FAILURE; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATIC ENCEPHALOPATHY; MALE; METHYSERGIDE; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; THIOACETAMIDE;

EID: 0030012377     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tyce GM, Flock EV, Owen Ca Jr, Stobie GMC, David C: 5-hydroxyindole metabolism in the brain after hepatectomy. Biochem Pharmacol 1967, 16:979-992.
2. Curzon G, Kantameneni BD, Winch J, Rojas-Bueno A, Murray-Lyon IM, Williams R: Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem 1973, 21:137-145.
3. Cummings MG, James JH, Soeters PB, Foster J, Fischer JE: Regional brain study of indoleamine metabolism in the rat in acute hepatic failure. J Neurochem 1976, 27:741-746.
4. Herlin PM, James JH, Hochbauer CA, Fischer JE: Effect of total hepatectomy and administration of branched chain amino acids on regional norepinephrine, dopamine and amino acids in rat brain. Ann Surg 1983, 198:172-177.
5. Mans AM, Hawkins RA: Brain monoamines after portacaval anastomosis. Met Brain Dis 1986, 1:45-52.
6. Yurdaydin C, Hörtnagl H, Steindl P, Zimmermann C, Pifl C, Singer EA, et al.: Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology 1990, 12:695-700.
7. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R: Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976, 6:387-394.
8. Jellinger K, Riederer P, Kleinberger G, Wuketich ST, Kothbauer P: Brain monoamines in human hepatic encephalopathy. Acta Neuropathol (Berl) 1978, 43:63-68.
9. Bergeron M, Reader TA, Layrargues GP, Butterworth RF: Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 1989, 14:853-859.
10. Bugge M, Bengtsson F, Nobin A, Jeppsson B, Herlin P: The turnover of brain monoamines after total hepatectomy in rats infused with branched chain amino acids. World J Surg 1987, 11:810-817.
11. Bugge M, Bengtsson F, Nobin A, Jeppsson B, Herlin P: The effect of liver ischemia on brain monoamine synthesis in the rat. Res Exp Med 1987, 187:119-130.
12. Riederer P, Kienzl E, Jellinger G, Wuketich S, Wesemann W: Molecular aspects of neurotransmitter-receptor changes in hepatic encephalopathy. In Advances in Hepatic Encephalopathy and Urea Cycle Diseases. Edited by Kleinberger G, Ferenci P, Riederer P, Thaler H. Basel: Karger; 1984:373-384.
13. Ferenci P, Püspök A, Steindl P: Current concepts in the pathophysiology of hepatic encephalopathy. Eur J Clin Invest 1992, 22:573-581.
14. DeSimoni MG, Sokola A, Fodritto F, Dal'Toso G, Algeri S: Functional meaning of tryptophan-induced increase of 5-HT metabolism as clarified by in vivo voltametry. Brain Res 1987, 411:819-824.
15. Lookingland KJ, Shannon NJ, Chapin DS, Moore KE: Exogenous tryptophan increases synthesis, storage, and intraneuronal metabolism of 5-hydroxytryptamine in the rat hypothalamus. J Neurochem 1986, 47:205-212.
16. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, et al.: Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats. Characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 1989, 9:594-601.
17. Bures J, Buresova O, Huston JP: Innate and motivate behavior. In Techniques and Basic Experiments for the Study of Brain and Behavior. New York: Elsevier North Holland; 1976:37-45.
18. A-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology 1991, 14:963-968.
19. 1 recognition sites. J Recept Res 1988, 8:59-81.
20. 2- antagonists. Drug Dev Res 1986, 8:133-140.
21. Van Nueten JM, Schnurkes JAJ, De Ridder WJE: Comparative pharmacological profile of ritanserin and ketanserin. Drug Dev Res 1986, 8:187-195.
22. Vorobioff J, Garcia-Tsao G, Groszmann R, Aceves G, Picabea E, Villavicencio R, et al.: Long term hemodynamic effect of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients. Hepatology 1989, 9:88-91.
23. Hadengue A, Lee S, Morcan R: Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotoninergic mechanisms in portal hypertension. Hepatology 1987, 7:644-647.
24. Krulich L, McCann SM, Mayfield MA: On the mode of the prolactin release-inhibiting action of the serotonin blockers metergoline, methysergide and cyproheptadine. Endocrinology 1981, 108:1115-1124.
25. Saxena PR: Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol 1974, 27:99-105.
26. Wilkinson LO, Auerbach SB, Jacobs BL: Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia. J Neurosci 1991, 11:2732-2741.
27. 1A agonistic properties. Hepatology 1994, 20:A109.
28. Saxena PR, Bolt GR, Dhasmana KM: Serotonin agonist and antagonists in experimental hypertension. J Cardiovasc Pharmacol 1987, 10(suppl.):12-18.
29. Antonaccio MJ, Coté D: Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive rats. Eur J Pharmacol 1976, 36:451-456.
30. Myers RD: Hypothalamic control of thermoregulation: neurochemical mechanisms. In Handbook of the Hypothalamus, Vol. 3. Edited by Morgane PJ, Pankseep J. New York: Marcel Dekker; 1980:83-210.
31. Peeling J, Shoemaker L, Gauthier T, Benarroch A, Sutherland GR, Minuk GY: Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am J Physiol 1993, G572-G578.
32. Delorme ML, Denis J, Nordlinger B, Boschat M, Opolon P: Relationship between plasma and brain tryptophan in pigs during experimental hepatic coma before and after hemodialysis with selective membranes. J Neurochem 1981, 36:1058-1066.